agaricus blazei murill
Botanicalexperimental
Clinical trial activity
5 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
2
Phase 4
0
Earliest trial started Jul 1, 2005 (NCT00131287)
Timeline
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- agaricus blazei murill
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07195552 | N/A | Jul 1, 2024 | Natural Immune Systems Inc |
| NCT03198455 | N/A | Feb 29, 2016 | ImmunoPharma AS, University of Oslo |
| NCT01496053 | Phase 2/Phase 3 (Phase 3) | Dec 1, 2011 | ImmunoPharma AS, Osaka University, University of Oslo |
| NCT01106742 | Phase 2 | Mar 1, 2009 | University of Oslo |
| NCT00131287 | Phase 3 | Jul 1, 2005 | Taipei Medical University, Taiwan Biotech Co., Ltd. |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Oslo | Academic/Hospital | 3 | 2 | 3 | 2009 |
| ImmunoPharma AS | For profit | 2 | 0 | 2 | 2011 |
| Natural Immune Systems Inc | For profit | 1 | 1 | 1 | 2024 |
| Osaka University | Academic/Hospital | 1 | 1 | 1 | 2011 |
| Taipei Medical University | Academic/Hospital | 1 | 0 | 1 | 2005 |
| Taiwan Biotech Co., Ltd. | For profit | 1 | 1 | 1 | 2005 |
6 organizations
Page 1 / 1